Tumor immune escape in acute myeloid leukemia: Class II-associated invariant chain peptide expression as result of deficient antigen presentation

Research output: Contribution to journalEditorialAcademicpeer-review

9 Citations (Scopus)

Abstract

In this overview, we discuss the role of class II-associated invariant chain peptide (CLIP) in acute myeloid leukemia (AML), one of the few tumors expressing HLA class II. The clinical impact, function and regulation of CLIP expression on leukemic cells is addressed, indicating its potential as immunotherapeutic target in AML
Original languageEnglish
Pages (from-to)211-213
JournalOncoimmunology
Volume1
Issue number2
DOIs
Publication statusPublished - 2012

Cite this